Updated:
Cochlear Limited
Cochlear Americas, maker of the Nucleus cochlear implant, Osia bone conduction system, and Baha sound processors. HQ in Menlo Park, CA.
Cochlear Limited
Cochlear Limited, whose Americas division is headquartered in Menlo Park, California, manufactures hearing implants for people with moderate to profound hearing loss. The company’s core products span the Nucleus cochlear implant series, the Osia bone conduction system, and the Baha system. The company focuses on medical-device development across the hearing-restoration value chain. It sells directly to hospitals and clinics, with distribution covering the United States and Canada. Its product portfolio involves three named platforms: Nucleus cochlear implants, the Osia active bone conduction implant, and the Baha sound processors. Cochlear Americas maintains offices in San Francisco, New York, and Minneapolis alongside its Menlo Park headquarters. The company’s website features patient stories describing life before and after implantation, but does not disclose financial metrics, investment activity, or team size. No recent operational events are publicly available from the Americas division. Cochlear distinguishes itself from hearing-aid companies by focusing exclusively on surgically implanted devices, a regulatory and clinical pathway that creates a higher barrier to entry. The company’s parent, Cochlear Limited, is listed on the Australian Securities Exchange and reports global financials, but the Americas arm operates as a sales and service subsidiary without its own disclosed balance sheet. (Altss estimate)
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Menlo Park
Corporate office
Menlo Park, CA, United States
Additional offices
San Francisco, CA · New York, NY · Minneapolis, MN
Sector focus
Frequently asked questions
What is the relationship between Cochlear Americas and Cochlear Limited?
Cochlear Americas is the North American subsidiary of Cochlear Limited, an Australian publicly traded company (ASX: COH). The parent company reports global financials; the Americas division focuses on sales, marketing, and clinical support for the US and Canadian markets.
Does Cochlear Americas have an investment arm or deploy capital as a family office?
No. Cochlear Americas is a medical-device sales and service division. It does not function as a family office, asset manager, or investment vehicle. The parent company Cochlear Limited may have corporate development activities, but this is not disclosed for the Americas arm.
What products does Cochlear Americas sell?
Cochlear Americas markets three main product lines: the Nucleus cochlear implant system (including the new smart Nucleus Nexa), the Osia bone conduction implant system, and the Baha sound processors. These are surgically implanted hearing devices.
Who are the key executives at Cochlear Americas?
Cochlear Americas does not publicly list executive leadership on its website. The parent company's leadership includes CEO Dig Howitt; regional presidents may lead the Americas division but are not identified in available materials.
Where is Cochlear Americas headquartered?
The company lists offices in Menlo Park, San Francisco, New York, and Minneapolis. Menlo Park appears to be the primary headquarters for the Americas division.
Does Cochlear Americas disclose financials like AUM or revenue?
No. As a subsidiary, Cochlear Americas does not publish separate financial data. Global results are reported by the Australian parent company Cochlear Limited on the ASX.
What is the most recent product launch from Cochlear Americas?
The company highlights the Cochlear Nucleus Nexa System as the world's first smart cochlear implant system. The exact launch date is not specified on the site.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: